Domain Therapeutics SA, of Strasbourg, France, signed with Ono Pharmaceutical Co. Ltd., of Osaka, Japan, a collaboration agreement focused on discovering small molecules targeting G protein-coupled receptors.
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription